Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | JAK2 | O60674 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | JAK1 | P23458 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | TYK2 | P29597 | 1/20 | 0.37 |
| ▸ | JAK3 | P52333 | 1/20 | 0.37 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.37 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10238203 | 0.87 | ATM (0.47) | ATMPOLBLMNAGAASMN1; SMN2 | |
| SCHEMBL272573 | 0.87 | ATM (0.62) | ATMLMNAGAASMN1; SMN2 | |
| SCHEMBL3255460 | 0.86 | ATM (0.45) | ATMPOLBLMNAGAASMN1; SMN2 | |
| SCHEMBL13295595 | 0.86 | ATM (0.45) | ATMPOLBJAK2LMNAGAA | |
| SCHEMBL13304626 | 0.85 | ATM (0.46) | ATMLMNAGAAIRAK4DHODH | |
| SCHEMBL13304875 | 0.84 | ALDH1A1 (0.42) | ATMPOLBLMNAGAADHODH | |
| SCHEMBL3253740 | 0.84 | ATM (0.45) | ATMPOLBLMNAGAADHODH | |
| SCHEMBL273301 | 0.84 | ATM (0.45) | ATMIRAK4DHODH | |
| SCHEMBL3177328 | 0.83 | LMNA (0.53) | ATMPOLBLMNAGAAIRAK4 | |
| SCHEMBL4831743 | 0.80 | HPGD (0.59) | POLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2192115-B1 | 1,3-DIMETHYLBUTYLCARBOXANILIDES FOR CONTROLLING UNDESIRABLE MICRO-ORGANISMS | BAYER CROPSCIENCE AG (DE) | 2014-02-12 | — | — | EP | disclosed |
| EP-2192115-A1 | 1,3-dimethylbutylcarboxanilides for controlling undesirable micro-organisms | Bayer CropScience AG (DE) | 2010-06-02 | — | — | EP | disclosed |
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | BAYER CROPSCIENCE AG (DE) | 2007-08-23 | — | — | US | disclosed |
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | BAYER CROPSCIENCE AG (DE) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | MCRS1, MRM1, PADI1 | ATM 3233/4885POLB 1165/4885JAK2 1733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.